Envigo

Huntingdon, United Kingdom Founded: 2015 • Age: 11 yrs Acquired By Inotiv
Drug discovery and development services are provided using research models.

About Envigo

Envigo is a company based in Huntingdon (United Kingdom) founded in 2015 was acquired by Inotiv in November 2021.. The company has 2 employees as of April 05, 2024. Envigo offers products and services including Toxicology Services, Histology Services, Research Models, and DMPK Services. Envigo operates in a competitive market with competitors including Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others.

  • Headquarter Huntingdon, United Kingdom
  • Employees 2 as on 05 Apr, 2024
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Envigo Research Private Limited
  • Date of Incorporation 05 Apr, 2013
  • Jurisdiction Ahmedabad, Gujarat, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $678.52 K (USD)
    -41.6
    as on Mar 31, 2018
  • Net Profit
    $-1.51 M (USD)
    -1367.73
    as on Mar 31, 2018
  • EBITDA
    $-1.43 M (USD)
    -1115.85
    as on Mar 31, 2018
  • Latest Funding Round
    $1.71 M (USD), Grant

    Jan 01, 2016

  • Investors
  • Employee Count
    2

    as on Apr 05, 2024

  • Acquired by
    Inotiv

    & 1 more

    (Nov 04, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Envigo

Envigo offers a comprehensive portfolio of products and services, including Toxicology Services, Histology Services, Research Models, and DMPK Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Conducts studies to evaluate drug and chemical safety risks.

Processes tissues for analysis in nonclinical development.

Supplies genetically engineered models for scientific studies.

Analyzes drug metabolism and pharmacokinetics in vivo.

People of Envigo
Headcount 500-1000
Employee Profiles 132
Board Members and Advisors 6
Employee Profiles
People
Johnathan Furr
Director Developmental And Reproductive Toxicology
People
Robert Leasure Jr.
CEO
People
Herman Derix
Finance Manager EMEA
People
Beth A. Taylor
SVP, Finance & CFO

Unlock access to complete

Board Members and Advisors
people
Michael J. Harrington
Director
people
R. Matthew Neff
Director
people
Terry Coelho
Director

Unlock access to complete

Funding Insights of Envigo

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $1.7M
  • First Round

    (01 Jan 2016)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2016 Amount Grant - Envigo Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Envigo

Envigo has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include European Union, Inotiv Co and AnaPath. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Clinical development and regulatory services are provided by Inotiv.
Founded Year Domain Location
Specializes in histopathology, toxicology, and molecular pathology services for clients.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Envigo

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Envigo

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Envigo Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Envigo

Envigo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of drug discovery and preclinical development services
domain founded_year HQ Location
Provider of laboratory tests for physicians
domain founded_year HQ Location
Data analysis and statistical solutions are provided for life sciences.
domain founded_year HQ Location
Provider of clinical research, development, and commercialization services for life sciences
domain founded_year HQ Location
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
domain founded_year HQ Location
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Envigo

Frequently Asked Questions about Envigo

When was Envigo founded?

Envigo was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Where is Envigo located?

Envigo is headquartered in Huntingdon, United Kingdom.

How many employees does Envigo have?

As of Apr 05, 2024, the latest employee count at Envigo is 2.

What is the annual revenue of Envigo?

Annual revenue of Envigo is $678.52K as on Mar 31, 2018.

What does Envigo do?

Provider of drug discovery and development services using research models. It offers a full spectrum of services, from discovery and translational sciences to safety assessment and toxicology. These services encompass disease pharmacology (in vitro and in vivo), drug metabolism and pharmacokinetics (DMPK), bioanalysis, and cell and molecular biology. The company also provides research models and related services, including genetically engineered models, contract breeding, and surgical services. Support services include specialized histology and pathology, chemical services, and diet and bedding for research animals. Consulting services are available in areas such as DMPK data analysis and biomarker analysis.

Who are the top competitors of Envigo?

Envigo's top competitors include LabCorp, Charles River Laboratories and Cytel.

What products or services does Envigo offer?

Envigo offers Toxicology Services, Histology Services, Research Models, and DMPK Services.

Who are Envigo's investors?

Envigo has 3 investors. Key investors include European Union, Inotiv Co, and AnaPath.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available